| Dr Elizabeth Jeanette Delgiacco, DO | |
|
48 Estate Castle Coakley, St Croix, VI 00820 | |
| (340) 772-1551 | |
| (340) 776-1552 |
| Full Name | Dr Elizabeth Jeanette Delgiacco |
|---|---|
| Gender | Female |
| Speciality | Medical Oncology |
| Experience | 15 Years |
| Location | 48 Estate Castle Coakley, St Croix, Virgin Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255574125 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 2121 (Virgin Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gov Juan F Luis Hospital & Medical Ctr | St croix, VI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Delgiacco Medical | 8628347218 | 2 |
News Archive
Ellipse Technologies, Inc. announced it had completed the initial clinical study enrollment for its MAGECTM (MAGnetic Expansion Control) Technology in "At Risk Early Onset Scoliosis Patients."
In an effort to sort out why some viruses such as influenza, Ebola and West Nile are so lethal, a team of U.S. researchers plans a comprehensive effort to model how humans respond to these viral pathogens.
Biophor Diagnostics, Inc. announces that it has received FDA 510(k) clearance for sale and distribution of its seventh oral fluid screening assay based on the RapidFRET IVD Platform technology. This clearance completes the company's flagship panel for drugs of abuse screening in oral fluid.
Biomerix Corporation and Gel Company today announced a strategic distribution agreement for the Biomerix 3D Scaffold, a novel three-dimensional tissue scaffold. Under the agreement, Gel Company will market and distribute the Biomerix 3D Scaffold to researchers in the life science community across the United States.
› Verified 4 days ago
| Entity Name | Delgiacco Medical |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619418233 PECOS PAC ID: 8628347218 Enrollment ID: O20170713002534 |
News Archive
Ellipse Technologies, Inc. announced it had completed the initial clinical study enrollment for its MAGECTM (MAGnetic Expansion Control) Technology in "At Risk Early Onset Scoliosis Patients."
In an effort to sort out why some viruses such as influenza, Ebola and West Nile are so lethal, a team of U.S. researchers plans a comprehensive effort to model how humans respond to these viral pathogens.
Biophor Diagnostics, Inc. announces that it has received FDA 510(k) clearance for sale and distribution of its seventh oral fluid screening assay based on the RapidFRET IVD Platform technology. This clearance completes the company's flagship panel for drugs of abuse screening in oral fluid.
Biomerix Corporation and Gel Company today announced a strategic distribution agreement for the Biomerix 3D Scaffold, a novel three-dimensional tissue scaffold. Under the agreement, Gel Company will market and distribute the Biomerix 3D Scaffold to researchers in the life science community across the United States.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Jeanette Delgiacco, DO 9150 Estate Thomas, Suite 202, St Thomas, VI 00802-2612 Ph: (585) 259-3040 | Dr Elizabeth Jeanette Delgiacco, DO 48 Estate Castle Coakley, St Croix, VI 00820 Ph: (340) 772-1551 |
News Archive
Ellipse Technologies, Inc. announced it had completed the initial clinical study enrollment for its MAGECTM (MAGnetic Expansion Control) Technology in "At Risk Early Onset Scoliosis Patients."
In an effort to sort out why some viruses such as influenza, Ebola and West Nile are so lethal, a team of U.S. researchers plans a comprehensive effort to model how humans respond to these viral pathogens.
Biophor Diagnostics, Inc. announces that it has received FDA 510(k) clearance for sale and distribution of its seventh oral fluid screening assay based on the RapidFRET IVD Platform technology. This clearance completes the company's flagship panel for drugs of abuse screening in oral fluid.
Biomerix Corporation and Gel Company today announced a strategic distribution agreement for the Biomerix 3D Scaffold, a novel three-dimensional tissue scaffold. Under the agreement, Gel Company will market and distribute the Biomerix 3D Scaffold to researchers in the life science community across the United States.
› Verified 4 days ago
Dr. Risa M Nielsen, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Beeston Hill Medical Center, Suite 12, St Croix, VI 00820 Phone: 340-778-6680 Fax: 340-778-8869 | |
Raymond Cintron, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 61 Herman Hill, St Croix, VI 00820 Phone: 340-719-6300 Fax: 340-719-6301 |